0001209191-19-027161.txt : 20190502
0001209191-19-027161.hdr.sgml : 20190502
20190502210516
ACCESSION NUMBER: 0001209191-19-027161
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190430
FILED AS OF DATE: 20190502
DATE AS OF CHANGE: 20190502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ketchum Steven B
CENTRAL INDEX KEY: 0001289884
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21392
FILM NUMBER: 19793922
MAIL ADDRESS:
STREET 1: 2483 EAST BAYSHORE ROAD
STREET 2: SUITE 100
CITY: PALO ALTO
STATE: CA
ZIP: 94303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMARIN CORP PLC\UK
CENTRAL INDEX KEY: 0000897448
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL,
STREET 2: SHELBOURNE ROAD, BALLSBRIDGE
CITY: DUBLIN
STATE: L2
ZIP: 00000
BUSINESS PHONE: 353 1 6699 020
MAIL ADDRESS:
STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL,
STREET 2: SHELBOURNE ROAD, BALLSBRIDGE
CITY: DUBLIN
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC
DATE OF NAME CHANGE: 20000201
FORMER COMPANY:
FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC
DATE OF NAME CHANGE: 19930322
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-30
0
0000897448
AMARIN CORP PLC\UK
AMRN
0001289884
Ketchum Steven B
C/O AMARIN PHARMA, INC.
1430 ROUTE 206
BEDMINSTER
NJ
07921
0
1
0
0
Chief Scientific Officer
Ordinary Shares
2019-04-30
4
M
0
2604
1.40
A
357096
D
Ordinary Shares
2019-04-30
4
M
0
4166
2.50
A
361262
D
Ordinary Shares
2019-04-30
4
M
0
2771
2.95
A
364033
D
Ordinary Shares
2019-04-30
4
S
0
9541
18.6675
D
354492
D
Stock Option (Right to Buy)
1.40
2019-04-30
4
M
0
2604
0.00
D
2026-01-31
Ordinary Shares
2604
23436
D
Stock Option (Right to Buy)
2.50
2019-04-30
4
M
0
4166
0.00
D
2025-07-06
Ordinary Shares
4166
8332
D
Stock Option (Right to Buy)
2.95
2019-04-30
4
M
0
2771
0.00
D
2027-01-31
Ordinary Shares
2771
58687
D
The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Please see the section titled "Remarks" below for additional information.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.41 to $19.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016.
On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015.
On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2017.
In the case of a Change of Control (as defined in the Plan), the grants described in this Form 4 vest in full. As of the date of this Form 4, the Reporting Person owns or holds the right to acquire an aggregate of 1,498,974 Ordinary Shares of the Issuer in the form of Ordinary Shares, and stock options and Restricted Stock Units granted under the Plan, including but not limited to, certain performance-based Restricted Stock Units that are earned only if product revenues reach pre-defined annual milestone levels ranging from $300 million to $1.0 billion and, in certain cases, then vest only if the recipient remains with the company for an extended period of time.
/s/ Joseph T. Kennedy, by power of attorney
2019-05-02